{"title": "Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system.", "author": "Darvish; Maliheh; Moosavi-Nejad; Zahra; Siadat; Seyed Omid Ranaei; Fatemi; Fataneh; Khatibi; Ali", "url": null, "hostname": null, "description": null, "sitename": "Virus Res", "date": "2019-01-01", "cleaned_text": "Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system. Virus Res ; 326: 199047, 2023 [viral entry]as it [SARS-CoV-2]) host [cell]entry. RBD is the major target for developing viral inhibitors and [vaccines]. Expression of recombinant RBD in E.coli is highly scalable with a low- [cost] [procedure]despite its high expression level compared to expression in mammalian and [yeast] [cells]. Using an alternative natural adjuvant system instead of [alum]adjuvant, increased immunogenicity of sVNT is a simple and fast test that can be used instead of the conventional [virus] [neutralization a [safety]profile for [sodium alginate]which supported using it as an sujet MEDLINE ... LILACS LIS "}